Can a Blood Test Distinguish ME/CFS?

Study on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Focus on chromosome conformation profiling.

Sample size: 47 patients, 61 controls.

Developed Episwitch CFS test with 200 markers.

Sensitivity: 92 percent, specificity: 98 percent, accuracy: 96 percent.

Links identified with cytokine signaling and immune pathways.

Potential for personalized treatment strategies.

Findings align with previous ME/CFS research.